Intra-articular corticosteroid injection bests hydrostatic shoulder distention for short-term pain relief in idiopathic frozen shoulder: study

Idiopathic frozen shoulder (adhesive capsulitis) is a common and debilitating condition, characterized by progressive restriction of shoulder movement. Non-randomized interventional treatments, such as intraarticular corticosteroid injections and hydrostatic (hydrodilatation) distention, are commonly employed when conservative therapy fails.

Muhammad Anas Ghazi et al conducted a study to compare the short-term effectiveness of intra-articular corticosteroid injection versus hydrostatic distention, in terms of pain relief and functional improvement in patients with idiopathic frozen shoulder.

A total of 108 patients, aged 35-70 years, with frozen-phase idiopathic frozen shoulder (>3 months’ duration), were assigned to two treatment groups using non-random, consecutive allocation: Group A (n = 54) received an intra-articular corticosteroid injection, and Group B (n = 54) underwent hydrostatic shoulder distention. Patients were assessed at baseline, 4 weeks, and 12 weeks using the Visual Analog Scale (VAS) for pain and the Shoulder Pain and Disability Index (SPADI) for function.

Key findings of the study were:

• Both groups showed significant improvements in pain and function over time (p < 0.001).

• Group A demonstrated superior outcomes at 12 weeks in VAS (2.1 ± 0.9 vs. 2.6 ± 1.0; p = 0.027) and SPADI (28.6 ± 6.3 vs. 32.9 ± 6.5; p = 0.006).

• “Very satisfied” patients were more frequent in Group A (28 patients; 64.81%) than in Group B (35 patients; 51.85%).

The authors concluded – “In summary, this research shows that, for individuals with idiopathic frozen shoulder, intra-articular corticosteroid injections are superior to hydrostatic shoulder distention in terms of reducing pain and enhancing shoulder function. The data show that the corticosteroid injection group experienced better levels of pain relief, functional improvement, and patient satisfaction. In the short term, corticosteroid injections appear to provide more rapid and longer-lasting effects, even though both therapies are effective. Further evaluation of the long-term safety and effectiveness of these therapies in a broader and more diverse population will require additional studies with multicenter data and longer follow-up.”

Further reading:

Short-Term Comparative Effectiveness of Intraarticular Corticosteroid Injection Versus Hydrostatic Distention in Idiopathic Frozen Shoulder: A Prospective Interventional Study

Muhammad Anas Ghazi et al

Cureus 17(6): e86639. DOI 10.7759/cureus.86639

Powered by WPeMatico

Higher Dental Radiation Doses Tied to Increased Risk of Cavities in Head and Neck Cancer Patients: Study Finds

Ireland: A recent clinical investigation published in the Journal of Dentistry has revealed a significant link between dental radiation exposure and the development of tooth decay in patients undergoing radiotherapy for head and neck cancer (HANC). The study highlights the importance of dental care and dietary compliance before and after radiotherapy in reducing the risk of radiation-related oral complications.

The study emphasized that patients who did not adhere to oral hygiene and dietary recommendations were more likely to experience increased severity of tooth decay following treatment.

Conducted as a prospective cohort study, Ciaran Moore, Department of Restorative Dentistry and Periodontology, Dublin Dental University Hospital, Lincoln Place, Dublin, Ireland, and colleagues followed 151 patients who were deemed dentally fit before the start of their radiotherapy treatment. These individuals were monitored for 6 to 12 months post-treatment, during which their oral health was assessed using clinical evaluations and standardized questionnaires. Particular attention was given to the condition of teeth, the presence of xerostomia (dry mouth), and patients’ oral health-related quality of life.

The study revealed the following findings:

  • There was a clear linear relationship between dental radiation dose and the development of cavities.
  • Around 49% of patients developed new carious lesions during the follow-up period.
  • Affected individuals had an average of 3.7 decayed teeth each.
  • Every 10 Gray (Gy) increase in mean or maximum dental radiation dose raised the risk of developing post-radiotherapy caries by 26–32%, even after accounting for other variables.
  • Radiation to the parotid glands showed no impact on the incidence or severity of dental caries.
  • The localized effect of radiation appears to target the teeth directly rather than acting through reduced saliva production.
  • Higher caries risk was associated with the presence of pre-existing dental decay.
  • Continued intake of high-sugar dietary supplements contributed to an increased risk of caries.
  • Regular consumption of sugary beverages, such as tea or coffee with added sugar, also elevates the likelihood of dental decay.

The authors stress the clinical importance of these findings, noting that targeted radiation planning and strict oral care protocols could play a pivotal role in reducing dental complications for HANC patients. While radiation therapy is an essential component in treating head and neck cancers, its impact on dental health should not be overlooked.

The study provides crucial evidence supporting the need for multidisciplinary management of cancer patients, where dental professionals work closely with oncologists to mitigate preventable side effects of radiation therapy. Future research is encouraged to further explore protective interventions and refine radiotherapy techniques to minimize damage to dental structures.

Reference:

Moore, C., Markey, N., Donnelly, M., O’Neill, C., Cardwell, C., & McKenna, G. (2025). A prospective clinical study of the influence of dental and salivary gland radiation dose on dental caries development in patients with head and neck cancer. Journal of Dentistry, 105817. https://doi.org/10.1016/j.jdent.2025.105817

Powered by WPeMatico

H. pylori Infection linked to Colorectal Cancer, suggests Lancet study

A new study published in the journal of Lancet eClinical Medicine showed that Helicobacter pylori (H. pylori) infection might be a major risk factor for colorectal cancer development.

Recent studies points to a potential connection between colorectal cancer risk and Helicobacter pylori (H. pylori) infection. Therefore, this investigation was carried to investigate the relationship between H. pylori infection, anti-H. pylori medication, and colorectal cancer and its precursor, adenoma.

A total of 3,475 individuals underwent colonoscopies and H. pylori testing as part of a screening program in Zhejiang Province, China, between March 8 and December 29, 2023, as part of the observational study portion. The relationships between H. pylori infection and the risk of colorectal cancer and adenoma were examined using logistic regression models.

The relationships between H. pylori infection, anti-H. pylori therapy, and the risk of colorectal cancer and adenoma were also the subject of a meta-analysis. From the beginning until April 9, 2025, 3 databases (PubMed, Embase, and the Cochrane Library) were searched for pertinent research. 

The Newcastle–Ottawa Scale for case-control and cohort studies, as well as the guidelines provided by the Agency for Healthcare Research and Quality for cross-sectional studies, were used to assess the quality of the research. I2 statistics were used to quantify heterogeneity, and subgroup analyses were carried out to find possible causes.

This study evaluated publication bias using funnel plots and corrected for potential bias using Duval and Tweedie’s “trim-and-fill” methodology. The Grading of Recommendations, Assessment, Development, and Evaluation approach was used to gauge the degree of certainty in the evidence.

In comparison to normal or non-adenomatous lesions (n = 2199), this study discovered a statistically significant correlation between H. pylori infection and the risk of colorectal cancer (n = 31, OR = 2.57, 95% CI: 1.26–5.39) and adenoma (n = 1245, OR = 1.37, 95% CI: 1.19–1.59), particularly for advanced adenoma (n = 486, OR = 1.94, 95% CI: 1.59–2.38).

H. pylori infection had a positive correlation with colorectal cancer (OR = 1.59, 95% CI: 1.39–1.82, I2 = 89%) and adenoma (OR = 1.47, 95% CI: 1.36–1.59, I2 = 88%), particularly with advanced adenoma (OR = 1.77, 95% CI: 1.56–2.00, I2 = 65%), according to a meta-analysis of this and 54 other studies, which included 48,945,236 participants.

The overall odds ratio (OR) for colorectal neoplasia (adenoma or colon cancer) was 1.49 (95% CI: 1.39–1.60, I2 = 91%). Overall, this study found a considerably increased incidence of colorectal cancer and adenoma in people who had H. pylori infection, indicating that H. pylori infection might be a significant risk factor for colorectal cancer development.

Source:

Li, X., Tao, H.-Q., Zhao, J.-E., Zhu, J., Du, L.-B., Gerhard, M., & Li, W.-Q. (2025). Helicobacter pylori infection, anti-Helicobacter pylori treatment and risk of colorectal cancer and adenoma: an observational study and a meta-analysis. eClinicalMedicine, 84(103299), 103299. https://doi.org/10.1016/j.eclinm.2025.103299

Powered by WPeMatico

AIIMS Patna Gynaecology medico suicide: Doctors blame Excessive Workload, demand enforcement of duty hour regulations

New Delhi: Following the tragic death of a first-year postgraduate medico in AIIMS Patna’s Obstetrics and Gynaecology Department, the doctors have demanded urgent action against the institute’s management for its failure to implement work hour regulations and called for an independent investigation into the doctor’s death.

In a letter addressed to the Union Minister of Health and Family Welfare, Shri Jagat Prakash Nadda, the United Doctors Front (UDF) association highlighted that the doctor was made to work a 36-hour shift, which allegedly went unchecked by the institute’s HOD and Dean. As a result, he was overburdened, faced extreme toxicity, and endured excessive duty hours, ultimately pushing him to take the extreme step. 

The association held the management responsible for failing to implement work regulations or prevent bullying, calling it a gross dereliction of duty. “This preventable tragedy, driven by a toxic work culture, unchecked harassment, and excessive duty hours. Mental and physical harassment and unregulated workloads enabled a culture that destroyed Dr. ***,” the letter reads. 

Also read- AIIMS Patna MD Gynaecology medico found dead, doctors demand inquiry

It further raised concerns about the severe burnout crisis among India’s medical professionals, exacerbated by long working hours and inadequate mental health support. They alleged that resident doctors are working 70-100 hours per week, which is a clear violation of the AIIMS 48-hour limit. 

UDF also criticised the institute’s handling of the situation following the doctor’s death. The association alleged that the management showed neither sympathy nor regret towards the grieving parents. The deceased doctor’s parents, who travelled from Odisha to Patna, were reportedly denied a meeting with officials and had to move his body to PMCH Patna for post-mortem due to a lack of trust in the AIIMS administration. The association called this behaviour an example of the toxic culture fostered by the institute’s leadership.

Medical Dialogues recently reported that a junior resident doctor and a first-year postgraduate student in the department of Obstetrics and Gynaecology at All India Institute of Medical Sciences (AIIMS), Patna, allegedly committed suicide in his hostel room. Doctors at the institute reported that the medico injected a high dose of anaesthetic drug. Resident doctors and students of AIIMS alleged that the administration attempted to suppress the incident. They claimed that the authorities threatened the residents into silence and failed to properly attend to the deceased’s family, who were reportedly mistreated upon their arrival. 

The UDF has now demanded a transparent, external probe into the toxic culture, targeting the negligence in addressing harassment, bullying, and workload imbalances, with a public report within 60 days. They also demanded strict adherence to the 48-hour weekly work limit across AIIMS institutions, with monthly audits, automated scheduling systems, and penalties for violations to end exploitative hours.

Further, they called for the establishment of mandatory grievance redressal cells with anonymous reporting, regular mental health screenings, and compulsory counselling services across AIIMS campuses to combat bullying and support the mental well-being of resident doctors.

Commenting on the matter, Dr. Yagika Pareek, National Spokesperson, UDF said in a press release, “The loss of Dr. *** is a tragic wake-up call to enforce AIIMS’s own work hour policies. We urge immediate action to create sustainable, supportive work environments for India’s healthcare workforce.”

Also read- Patna NEET aspirant ends life, suicide note cites forced marriage

Powered by WPeMatico

Morepen Labs incorporates new step-down subsidiary in mainland Dubai

Gurugram: Morepen Laboratories Limited has announced the incorporation of a new step-down subsidiary, Morepen Medical Equipment Trading L.L.C, in mainland Dubai, United Arab Emirates (UAE).

The newly incorporated entity is a wholly owned subsidiary of Morepen Medipath Limited (formerly Morepen Medtech Limited) and aims to focus on the sales and marketing of medical devices’ products in the international market including Dubai, U.A.E., and others.

Morepen Labs indirectly holds a 60% of the shares in the Dubai-based company through Morepen Medipath.

Morepen Medipath Limited has subscribed
100 shares, of AED 1000 each, for an aggregate
amount of AED 100000.
The denomination of share has been changed from
AED 10 each to AED 1000
each, however, the
total capital, being AED 100000 remain unchanged.

Read also: CDSCO panel grants clearance to Morepen Labs to conduct BE studies for fatty liver disease drug Resmetirom

The new subsidiary, incorporated on July 22, 2025, will operate in the medical devices segment.

In June, Medical Dialogues reported the incorporation of MOREPEN LABS – FZCO, a wholly owned subsidiary of Morepen Labs in Dubai.

Read also: Morepen Labs incorporates wholly owned subsidiary in Dubai

In April, the company also announced an expansion of its salesforce, with plans to onboard over 1,000 professionals over the next three years. Of these, 200 new team members are expected to join in FY26. The recruitment drive is part of Morepen’s strategy to strengthen engagement with doctors, pharmacies, patients, and healthcare professionals across India.

Morepen Laboratories Ltd. is an Indian pharmaceutical company with a global footprint across 82 countries. All APIs are manufactured in-house at USFDA-approved facilities.

Read also: Morepen Labs plans to employ over 1000 professionals

Powered by WPeMatico

United Doctors Front announces National Core Committee for 2025-26

New Delhi: United Doctors Front (UDF), an organization dedicated to the rights and welfare of doctors and medical students, has announced its National Core Committee for the 2025-26 session. 

The 2025–26 term will place special emphasis on the safety and dignity of the medical community. The new team comprises both experienced experts and dedicated young doctors.

Dr Lakshya Mittal has been appointed as the Chairperson and National President. Dr Amit Vyas has been designated as the National Vice President, while Dr Arun K. Kumar takes over as the National General Secretary.

Also Read:Doctors Urge Union Health Minister to Implement Rotatory Headship at AIIMS, PGI Chandigarh

Dr Meer Wasim and Dr. Rakesh Beniwal have been given the role of State Joint Secretaries. Dr. Yagika Pareek and Dr. Bhanu Kumar have been appointed as State Spokespersons. 

The responsibility of the National Finance Secretary has been entrusted to Dr. Bharat Rathore. Additionally, Dr. Aditi Singh (Social Media Secretary), Swami Das (Head, National RTI Cell), Dr. Charu Mathur and Satyam Singh Rajput (Legal Advisors), and Dr. Lay Paghadar (Divyangjan Secretary) have been announced. Dr. Akshat Gautam and Dr. Manoj Jat have been appointed as JR Secretaries.

Furthermore, Dr. Shubhapratap Solanki, Dr. Hanuman Bishnoi, Dr. Krishna Sharma, and Dr. Alok Singh have been appointed as North Zone Secretaries. Dr. Hariharan will serve as the South Zone Secretary. Dr. Anshuman Patra, Dr. Jugal Krishna Dole, and Dr. Amit Kumar Giri will hold the positions of East Zone Secretaries. Dr. Ajit Singh Shekhawat, Dr. Samyak Bansal, and Dr. Sukharam Gehlot will serve as West Zone Secretaries. Dr. Vikas Milky, Dr. Sasanpuri Sai Santosh Teja, and Dr. Rajat Khurana have been appointed as Central Zone Secretaries.

Dr. Harshit Naranival, Dr. Divjot Singh Kalra, and Dr. Akshay Sharma have been made Anti-Ragging Secretaries. The role of Mental Health Secretaries will be taken up by Dr. Prashant Sharma, Dr. Lalit Tanwar, and Dr. Anshita Chhabra. Dr. Kanchan Dochaniya and Rhythm will lead the Research Cell, while Dr. Abhinandana Tokas and Dr. Khushboo Vyas have been given charge of the Academic Cell. Dr. Yogendra Pal Yadav and Dr. Vansh Chopra have been appointed as FMG Secretaries. The IT Cell will be handled by Dr. Rakesh Beniwal and Dr. Gopal Singh.

In the Student Wing, Batul Fatima, Amrit Singh, Aryan Kansal, and Akshat Tiwari have been appointed as Secretaries. Dr. Jagpati Bhardwaj will lead the Dental Wing. The Social Media team includes Dr. Shashank Tiwari, Deependra, Pragya Chauhan, Tripti Yadav, Dr. Ayaan Bhati, I.V. Sabarish, and Sheikh Kaifuddin.

National President Dr. Lakshya Mittal stated that the new team will take concrete steps toward major reforms in medical education, ensuring defined working hours for resident doctors, and preventing violence against doctors. The goal is to protect the dignity, safety, and well-being of doctors while ensuring quality healthcare services for every citizen.

Also Read:United Doctors Front Association Elects New Leadership for 2024-2025

Powered by WPeMatico

Jharkhand appoints 126 Specialist doctors through lowest honorarium bids

Ranchi: The Jharkhand government on Tuesday handed over appointment letters to 126 specialist doctors selected under the National Health Mission (NHM) through a first-of-its-kind bidding-based recruitment process.

This selection process allowed specialist doctors to choose their preferred postings by quoting the lowest honorarium.

According to an IANS report, at a function held at the IPH Auditorium in Namkum, Ranchi, on Tuesday, Health Minister Dr Irfan Ansari handed over appointment and posting letters to the selected doctors.

Under this innovative system, doctors were presented with a list of available health centres across the state. They were then allowed to select their preferred posting, with priority given to those quoting the lowest honorarium for their choice of location.

Also Read:Ranchi: 2,600-bed Super Speciality Hospital RIMS-2 set to boost Medical Tourism

Congratulating the newly appointed specialists, Dr Ansari said, “Our dream is to make every district of Jharkhand a Medicos City. We want every citizen to receive quality healthcare in their own district. These doctors are not just receiving appointments — they are being entrusted with responsibility. From now on, each of them is the ‘Health Minister’ of their hospital.”

Additional Chief Secretary Ajay Kumar Singh, who was also present, emphasised that the appointments are part of a broader mission to improve healthcare access across Jharkhand.

“This is more than a job — it’s a mission to bring specialist care to every corner of the state. Sadar Hospital in Ranchi is already emerging as a national model, and the Uttar Pradesh government has asked us to present our innovation,” he said.

The appointments include 22 pediatricians, 20 surgeons, 19 gynaecologists, 17 anesthetists, 11 general physicians, 10 orthopaedic surgeons, 9 ophthalmologists, 5 ENT specialists, 5 psychiatrists, 4 radiologists, and 4 dermatologists, reports IANS. 

Although the health department had initiated the process to appoint 219 doctors, only 126 applied and completed the procedure. The remaining 93 positions remain vacant.

As per the terms, the selected doctors must reside in government-provided accommodation and are prohibited from engaging in private practice.

The government believes that this approach will incentivise doctors to serve in rural and remote regions while improving the overall reach and quality of healthcare services. Plans are underway to extend this model to future appointments.

Notably, Jharkhand faces a severe shortage of doctors. Against a requirement of 37,000 doctors (based on population), only 7,500 are currently available. The scarcity is even more acute among specialists — just 300 are serving against 1,200 sanctioned posts.

Also Read:Jharkhand Health Department sees major reshuffle, 58 Medical Officers Transferred

Powered by WPeMatico

6 crore screened for Sickle Cell Disease; States Step Up Efforts

New Delhi: A total of 6 crore individuals have been screened for Sickle Cell Disease (SCD) against the targeted 7 crore under the National Sickle Cell Mission.

Among those screened, 2.15 lakh individuals diagnosed with the disease and 16.7 lakh carriers have been identified. Additionally, 2.6 crore health cards have been distributed by the respective states to the screened individuals. 

States including Madhya Pradesh, Gujarat, Rajasthan, Telangana, Karnataka, and Uttarakhand have demonstrated significant progress by achieving a high percentage of screening relative to their targets. The highest incidence of diagnosed cases has been reported in the states of Odisha, Chhattisgarh, Madhya Pradesh, Maharashtra, and Gujarat.

Also Read:Govt slashes Sickle Cell Test Kit Price below Rs 50

Screening for SCD is being conducted using validated Point-of-Care Testing (POCT) kits, which ensure rapid, reliable, and confirmatory results. Furthermore, a dedicated dashboard and a sickle cell disease portal have been established to consolidate screening data from all participating states.

Future priorities encompass intensifying screening efforts to meet the remaining target and ensuring follow-up and counselling services for individuals diagnosed as diseased or carriers.

The National Sickle Cell Anemia Elimination Mission was inaugurated on 1st July 2023 by the Hon’ble Prime Minister at Shahdol, Madhya Pradesh. The mission aims to eliminate sickle cell anemia in India by 2047 through the creation of awareness, universal screening of 7 crore individuals aged 0-40 years in affected tribal areas by FY 2025-26, and provision of counselling through collaborative efforts of central ministries and state governments.

Medical Dialogues had earlier reported that to support the eradication of Sickle cell anaemia, the government has significantly reduced the cost of testing kits to less than Rs 50. The initiative is part of the National Sickle Cell Elimination Programme, which aims to screen a population of seven crore across the country. 

Also Read:India offers Rs 10 crore reward for new drug to treat sickle cell disease

Powered by WPeMatico

Biocon Biologics launches Nepexto in Australia

Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced it has launched Nepexto, a biosimilar to the
reference product Enbrel (Etanercept), in Australia.

Nepexto will be promoted by Generic Health,
the company’s local partner and a provider of generic prescription, injectable and over-thecounter medicines, to expand access to patients in Australia.

Etanercept is a fusion-protein that inhibits tumor necrosis factor (TNF) and is used in the treatment
of autoimmune diseases like rheumatoid arthritis, juvenile idiopathic arthritis and psoriatic
arthritis, plaque psoriasis and ankylosing spondylitis.

Since receiving EU marketing authorization in 2020, Nepexto has earned broad adoption across
Europe.

Read also: Malaysia extends Insulins supply contract with Biocon Biologics arm, Duopharma Marketing for additional 6 months

“Following the 2022 acquisition and vertical integration of the biosimilars business globally,
Biocon Biologics is building on the solid foundation to strategically expand Nepexto into new
markets worldwide and further strengthen our immunology offering,” the company’s spokesperson stated.

Nepexto is a registered trademark of Biosimilars New Co Limited, a Biocon Biologics Company.

Read also: Phase 3 study comparing Yesintek with Stelara in adult patients with chronic plaque psoriasis shows positive results: Biocon Biologics

Biocon Biologics is a global player in biosimilars and insulin production and has achieved many “firsts” in the industry including the first to receive approval of a trastuzumab in the United States, OGIVRI (Trastuzumab-dkst), as well as FULPHILA (Pegfilgrastim-jmdb) and the first U.S. approval of an interchangeable biosimilar for SEMGLEE (insulin glargine). Biocon Biologics has a comprehensive portfolio of in-market and in-development biosimilar products across multiple therapies, including seven approved biosimilars in the United States and six in Canada, with a development pipeline of 20 biosimilar assets, including insulins and monoclonal antibodies spanning multiple therapy areas.

Read also: Biocon Biologics gets EU nod for bone disease treatments, including Osteoporosis, giant cell tumour of bone

Powered by WPeMatico

Faculty uproar over temporary deputation to Baramati Medical College

Pune: A decision to temporarily transfer 12 senior medical professors — 11 from Pune’s prestigious B.J. Medical College (BJMC) and one from Solapur’s Government Medical College (GMC) — to the newly established Punyashlok Ahilyabai Devi Holkar Government Medical College in Baramati has sparked discontent among the faculty involved. 

An official letter, signed by Anil Bhandari, Commissioner of Medical Education and AYUSH, aimed to address the acute faculty shortage at the newly established government medical college.

In the letter, addressed to the deans of BJMC and GMC Solapur, Bhandari stated that the deputed professors are being assigned on a temporary basis and that their existing pay scales and grade structures will remain unchanged during this period.

Also Read: UP: Worried about low attendance, 2nd year MBBS hangs self in hostel room

Speaking to TOI, Bhandari said, “As per the National Medical Council (NMC) norms, there is excess faculty in these two colleges. So, we have deputed some staff to Baramati Medical College, where students have already taken admission, and it is the need of the hour. It is a temporary deputation, and we are getting new recruits through MPSC in a month. However, we will look into their objections.”

BJMC Dean Dr. Eknath Pawar confirmed that he has not yet relieved the deputed professors as he is awaiting formal communication. Speaking to TOI, he said, “The senior professors met me. I have not yet relieved them since I have not yet received the letter. We, too, have a shortage of faculty, and if these professors go to Baramati, then our students will face difficulties.”

GMC Solapur Dean Dr. R. D. Jaykar confirmed that only one professor from his college has been deputed and has already been relieved of duties.

The move has been met with resistance at BJMC. The professors affected include senior heads and associate professors from critical departments such as gynaecology, internal medicine, microbiology, surgery, paediatrics, orthopaedics, obstetrics, pharmacy, and anatomy.

On Tuesday, the deputed professors submitted a formal letter to the commissioner’s office, requesting a rollback of the decision.

Faculty and postgraduate students at BJMC have questioned the rationale behind pulling resources from one of the state’s oldest and most prominent medical colleges to staff a new institution that is still in the process of becoming fully operational.

Also Read: Pune’s Atal Bihari Vajpayee Medical College faces Faculty Shortage, Infrastructure Gaps

One of the affected professors said he may resign if he is forced to go to Baramati. “Many of us have been here for a long time and built a strong reputation. Some others have been at BJMC for their entire careers, but have not been told to go to Baramati,” reports TOI.

Powered by WPeMatico